BridgeMD
New treatment option for Coronary Artery Disease
Official title The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
ClinicalTrials.gov ID: NCT06798714
What this study is testing
What is NSAID?
NSAID is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for coronary artery disease.
Also referred to as non-steroidal anti-inflammatory drugs.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Development of a new comprehensive method for perioperative prevention of atrial fibrillation paroxysms in cardiac surgery patients at the hospital stage. It is planned to recruit 70 patients who will undergo pericardial fenestration during the operation using the original technique during coronary artery bypass grafting (Patent No.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Elective coronary artery bypass grafting on pump;
- signed informed consent to participate in the study.
You likely can't join if
- Reduced left ventricular ejection fraction (≤35%);
- Valvular heart disease requiring surgical correction;
- Liver failure with an increase in liver transaminases ≥1.5 times;
- Renal failure (GFR\<35 mL/min/1.73 m2 calculated with CKD-EPI);
- Permanent, persistent or paroxysmal atrial fibrillation;
- Previously implanted pacemaker;
See the full eligibility criteria
- Elective coronary artery bypass grafting on pump;
- signed informed consent to participate in the study.
- Reduced left ventricular ejection fraction (≤35%);
- Valvular heart disease requiring surgical correction;
- Liver failure with an increase in liver transaminases ≥1.5 times;
- Renal failure (GFR\<35 mL/min/1.73 m2 calculated with CKD-EPI);
- Permanent, persistent or paroxysmal atrial fibrillation;
- Previously implanted pacemaker;
- Hypersensitivity to colchicine;
- Neutropenia;
- History of alcoholism;
- Refusal to sign informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Tomsk, Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tomsk, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.